Next-Gen Sequencing Market to Reach USD 50 Billion by 2032 at 22.0% CAGR

 

The global Next-Generation Sequencing (NGS) market Size, valued at USD 8.3 billion in 2023, is on a transformative path, expected to surge to USD 50.0 billion by 2032, according to a comprehensive market analysis. This unprecedented growth reflects a compound annual growth rate (CAGR) of 22.0% during the forecast period from 2024 to 2032.

NGS has revolutionized the field of genomics and molecular biology by allowing rapid sequencing of entire genomes at a fraction of the cost and time of traditional methods. Its applications have expanded far beyond basic research to encompass personalized medicine, oncology, infectious diseases, reproductive health, and agricultural genomics.

Get Free Sample Report on Next Generation Sequencing Market  

https://www.snsinsider.com/sample-request/3720

Market Overview

Next-generation sequencing, also known as high-throughput sequencing, has become a cornerstone of precision medicine and genetic diagnostics. Continuous innovation, plummeting sequencing costs, and rising demand for advanced genomic analysis are the major driving forces behind the market’s explosive expansion.

The market’s trajectory is further supported by growing investments in genomic research by public and private sectors, alongside increasing collaborations among biotechnology companies and academic institutions.

Market Drivers

1. Widespread Adoption in Clinical Applications

NGS is increasingly used in clinical diagnostics, particularly in oncology for identifying mutations and guiding targeted therapies. Liquid biopsy, a non-invasive cancer detection method based on NGS, is gaining momentum, driving market growth.

2. Rising Demand for Precision Medicine

As healthcare shifts towards personalized treatment regimens, NGS plays a pivotal role in delivering genetic insights that shape tailored therapeutics. The push for individualized medicine across cancer, cardiovascular, and rare diseases significantly boosts demand.

3. Decreasing Cost of Sequencing

The cost of sequencing a human genome has plummeted from nearly USD 100 million to under USD 1,000, thanks to technological advancements. This affordability is opening new avenues for research, diagnostics, and consumer genomics.

4. Technological Advancements

Continuous improvements in NGS platforms, bioinformatics tools, and data analytics are making sequencing faster, more accurate, and scalable. Third-generation sequencing technologies are expanding possibilities even further.

5. Increased Genomic Research Funding

Government initiatives such as the Precision Medicine Initiative (USA) and Genomics England (UK) have significantly increased funding for genomic research, supporting the expansion of sequencing services worldwide.

Key Market Applications

➤ Oncology

NGS is transforming cancer research and care. Tumor profiling, mutation detection, and treatment resistance monitoring are key oncology applications fueling the NGS market.

➤ Infectious Disease Diagnosis

NGS enables pathogen identification, viral genome surveillance, and antibiotic resistance tracking, playing a crucial role during outbreaks such as COVID-19.

➤ Reproductive Health

Applications include non-invasive prenatal testing (NIPT), carrier screening, and embryo selection in IVF, with growing demand from both healthcare providers and patients.

➤ Agricultural Genomics

NGS aids crop improvement, animal breeding, and food safety testing, driving adoption in agricultural biotechnology.

➤ Forensics and Anthropology

NGS supports DNA profiling, ancestry testing, and ancient DNA sequencing, expanding the scope of law enforcement and academic studies.

Key Market Segments:

By Product

  • Consumables
  • Platforms

By Technology

  • WGS
  • Whole Exome Sequencing
  • Targeted Sequencing & Resequencing

By Workflow

  • Pre-Sequencing
  • Sequencing
  • NGS Data Analysis

By Application

  • Oncology
  • Clinical Investigation
  • Reproductive Health
  • HLA Typing/Immune System Monitoring
  • Metagenomics
  • Epidemiology & Drug Development
  • Agrigenomics & Forensics
  • Consumer Genomics

By End User

  • Academic Research
  • Clinical Research, Hospitals & Clinics
  • Pharma & Biotech Entities
  • Other Users

Key Players in the Next-generation sequencing Market

·         Illumina (NovaSeq Series, MiSeq, NextSeq Series)

·         F. Hoffman-La Roche Ltd. (GeneReader, NimbleGen)

·         QIAGEN (GeneReader NGS System, QIAseq)

·         Thermo Fisher Scientific, Inc. (Ion Proton System, Ion S5 System, Applied Biosystems GeneMapper Software)

·         Bio-Rad Laboratories, Inc. (ddPCR (Droplet Digital PCR))

·         Oxford Nanopore Technologies (MinION, GridION, PromethION)

·         PierianDx (PierianDx Platform)

·         Genomatix GmbH (Genomatix Suite)

·         DNASTAR, Inc. (Lasergene Genomics Suite)

·         Perkin Elmer, Inc. (BioQule NGS System)

·         Eurofins GATC Biotech GmbH (GATC Biotech NGS Services)

·         BGI (BGISEQ Series)

·         PacBio (Sequel II System)

·         Agilent Technologies 

 

Future Outlook

The Next-Generation Sequencing market is poised for remarkable transformation as sequencing becomes a foundational technology across industries. The convergence of AI, bioinformatics, cloud computing, and personalized healthcare will redefine genomic medicine.

Future growth will be characterized by:

  • Miniaturization and portability of sequencing devices
  • Increased integration of NGS in primary care
  • Emergence of direct-to-consumer (DTC) genomics
  • Enhanced interoperability between sequencing and electronic health records (EHRs)

Conclusion

The Next-Generation Sequencing market is on a steep upward curve, backed by its expanding role in precision medicine, clinical diagnostics, and biotech innovation. With a projected valuation of USD 50.0 billion by 2032, NGS is set to revolutionize healthcare, agriculture, and research at an unprecedented pace.

Stakeholders across the value chain—from researchers and clinicians to biotech firms and policymakers—must gear up to harness the full potential of this transformative technology.

 About US

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Jagney Dave - Vice President of Client Engagement

Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK).

 

Comments

Post a Comment

Popular posts from this blog

Global Postpartum Care Market Forecast Shows 6.54% CAGR Growth Through 2032

  The Postpartum Products Market Size , valued at USD 2.53 billion in 2023 , is projected to reach USD 4.47 billion by 2032 , expanding at a CAGR of 6.54% over the forecast period from 2024 to 2032 , according to the latest industry research report. Postpartum products have become essential in modern maternity care, supporting new mothers in recovering from childbirth both physically and emotionally. These products—which include perineal care items, nursing accessories, postpartum garments, supplements, and more—play a vital role in enhancing comfort, hygiene, healing, and overall well-being during the postnatal period. Get Free Sample Report on Postpartum Products Market   https://www.snsinsider.com/sample-request/3361 Key Market Drivers 1. Increasing Global Birth Rate and Focus on Maternal Health Although some regions face declining birth rates, globally, over 140 million births occur annually , according to WHO. A significant portion of this population experien...
Read more

Platelet Rich Plasma Industry Booms: CAGR of 14.98% Forecasted Through 2032

  The global Platelet Rich Plasma (PRP) market Size is on a transformative growth trajectory, with the market size projected to rise from USD 0.75 billion in 2023 to USD 2.62 billion by 2032 , expanding at a Compound Annual Growth Rate (CAGR) of 14.98% during the forecast period of 2024–2032 . PRP therapy, known for its regenerative and healing properties, is gaining considerable traction in fields such as orthopedics, dermatology, sports medicine, and aesthetics . What is Platelet Rich Plasma (PRP)? Platelet Rich Plasma (PRP) is an autologous concentration of human platelets in a small volume of plasma. It has emerged as a promising treatment modality due to its rich content of growth factors , which play a pivotal role in tissue repair, regeneration, and inflammation modulation. PRP is prepared from a patient’s own blood and injected into the injured or targeted tissue to promote natural healing. Get Free Sample Report on Platelet Rich Plasma Market   http://snsins...
Read more

Hormone Replacement Therapy Market to Reach USD 29.02 Billion by 2032

  The global  Hormone Replacement Therapy (HRT) Market Share , which stood at  USD 18.36 billion in 2023 , is projected to grow to  USD 29.02 billion by 2032 , expanding at a  CAGR of 5.31%  from  2024 to 2032 , according to a new market analysis. This steady growth is attributed to increasing life expectancy, heightened awareness about menopausal and andropausal health, advancements in drug delivery systems, and the expanding base of patients seeking symptom relief and quality-of-life improvement. HRT, which involves supplementing hormones like estrogen, progesterone, or testosterone, plays a crucial role in managing age-related hormonal imbalances in both women and men. Get Free Sample Report on Hormone Replacement Therapy Market   https://www.snsinsider.com/sample-request/2977 Market Overview Hormone replacement therapy is primarily used to treat hormonal imbalances, particularly in postmenopausal women and aging men. Conditions such ...
Read more